et al., Zaporozhye Med. J.,
RCT 200 patients in Ukraine, 99 treated with IV quercetin/polyvinylirolidone followed by oral quercetin/pectin, showing improved recovery with treatment.
risk of no recovery, 29.4% lower, RR 0.71, p = 0.50, treatment 9 of 99 (9.1%), control 13 of 101 (12.9%).
recovery time, 18.2% lower, relative time 0.82, p = 0.03, treatment 99, control 101.
Zupanets et al., 9/1/2021, Randomized Controlled Trial, Ukraine, Europe, peer-reviewed, 14 authors.
Effect extraction follows pre-specified rules
prioritizing more serious outcomes. For an individual study the most serious
outcome may have a smaller number of events and lower statistical signficance,
however this provides the strongest evidence for the most serious outcomes
when combining the results of many trials.